NOXAFIL

  • lupin launches posaconazole delayed release tablets

    Lupin launches Posaconazole delayed-release tablets

    In a regulatory filing, Lupin Ltd announced launch of Posaconazole delayed-release tablets, 100 mg, after its alliance partner AET Pharma US Inc. received an approval for its abbreviated new drug application from USFDA.

Join the community of 2M+ industry professionals

Subscribe to our Daily Newsletter

By continuing you agree to our Privacy Policy & Terms & Conditions

Download ETHealthworld App for Realtime updates

Seamless reading experience. Save your favourite.

Scan to download App

Download ETHealthworld App for Realtime updates of content you follow

  • Seamless reading experience
  • Save your favourite articles
Advertisement
Advertisement